Inflammatory factors and exercise in chronic kidney disease

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Dungey, Maurice ^a,b   Hull, Katherine L ^b,c   Smith, Alice C ^b,c   Burton, James O ^b,c   Bishop, Nicolette C ^a,b  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

^c Maurice Shock Medical Sciences Building ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

AEROBIC EXERCISE; ANTIINFLAMMATORY ACTIVITY; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; ENERGY EXPENDITURE; EXERCISE; GLOMERULUS FILTRATION RATE; HABIT; HEALTH STATUS; HEMODIALYSIS; HUMAN; INFLAMMATION; MALNUTRITION; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SEDENTARY LIFESTYLE; SURVIVAL RATE; WASTING SYNDROME;

EID: 84878690738     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/569831     Document Type: Review

References (116)

1. Longmore M., Wilkinson I. B., Davidson E. H., Foulkes A., Mafi A. R., Oxford Handbook of Clinical Medicine 2010 8th Oxford, UK Oxford University Press
2. National Collaborating Centre for Chronic Conditions, Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care 2008 London, UK Royal College of Physicians
3. Steenkamp R., Castledine C., Feest T., Fogarty D., UK Renal Registry 13th Annual Report (December 2010): Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses. Nephron 2011 119 2 27 52
4. Kumar P. J., Clark M. L., Kumar and Clark's Clinical Medicine 2009 7th Edinburgh, UK Saunders Elsevier
5. Zhang Q. L., Rothenbacher D., Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008 8 117 2-s2.0-43549090868 10.1186/1471-2458-8-117 (Pubitemid 351678123)
6. Tonelli M., Wiebe N., Culleton B., House A., Rabbat C., Fok M., McAlister F., Garg A. X., Chronic kidney disease and mortality risk: a systematic review. Journal of the American Society of Nephrology 2006 17 7 2034 2047 2-s2.0-33745852282 10.1681/ASN.2005101085 (Pubitemid 44036188)
7. Keith D. S., Nichols G. A., Gullion C. M., Brown J. B., Smith D. H., Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Archives of Internal Medicine 2004 164 6 659 663 2-s2.0-1642413198 10.1001/archinte.164.6.659 (Pubitemid 38392981)
8. Drey N., Roderick P., Mullee M., Rogerson M., A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. American Journal of Kidney Diseases 2003 42 4 677 684 2-s2.0-0141620215 10.1016/S0272-6386(03)00916-8 (Pubitemid 37187367)
9. Sarnak M. J., Levey A. S., Schoolwerth A. C., Coresh J., Culleton B., Hamm L. L., McCullough P. A., Kasiske B. L., Kelepouris E., Klag M. J., Parfrey P., Pfeffer M., Raij L., Spinosa D. J., Wilson P. W., Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003 108 17 2154 2169 2-s2.0-0141468244 10.1161/01.CIR.0000095676. 90936.80 (Pubitemid 37337595)
10. Schiffrin E. L., Lipman M. L., Mann J. F. E., Chronic kidney disease: effects on the cardiovascular system. Circulation 2007 116 1 85 97 10.1161/CIRCULATIONAHA.106.678342 (Pubitemid 47016250)
11. Libby P P., Inflammation and cardiovascular disease mechanisms. The American Journal of Clinical Nutrition 2006 83 2 456 460
12. Khansari N., Shakiba Y., Mahmoudi M., Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Patents on Inflammation and Allergy Drug Discovery 2009 3 1 73 80 2-s2.0-61449125226 10.2174/187221309787158371
13. Garg A. X., Blake P. G., Clark W. F., Clase C. M., Haynes R. B., Moist L. M., Association between renal insufficiency and malnutrition in older adults: results from the NHANES III. Kidney International 2001 60 5 1867 1874 2-s2.0-0034783506 10.1046/j.1523-1755.2001.00001.x (Pubitemid 32999992)
14. Ortega O., Rodriguez I., Gallar P., Carreño A., Ortiz M., Espejo B., Jimenez J., Gutierrez M., Oliet A., Vigil A., Significance of high C-reactive protein levels in pre-dialysis patients. Nephrology Dialysis Transplantation 2002 17 6 1105 1109 2-s2.0-0035992051 (Pubitemid 34746216)
15. Oberg B. P., McMenamin E., Lucas F. L., McMonagle E., Morrow J., Ikizler T. A., Himmelfarb J., Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney International 2004 65 3 1009 1016 2-s2.0-1342322653 10.1111/j.1523-1755.2004.00465.x (Pubitemid 38251077)
16. Zaoui P., Hakim R. M., The effects of the dialysis membrane on cytokine release. Journal of the American Society of Nephrology 1994 4 9 1711 1718 2-s2.0-0028391291
17. Schouten W. E. M., Grooteman M. P. C., van Houte A. J., Schoorl M., van Limbeek J., Nubé M. J., Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrology Dialysis Transplantation 2000 15 3 379 384 2-s2.0-0034002552 (Pubitemid 30116473)
18. Kaysen G. A., Inflammation nutritional state and outcome in end stage renal disease. Mineral and Electrolyte Metabolism 1999 25 4-6 242 250 2-s2.0-0033376285 (Pubitemid 30099672)
19. Arici M., Walls J., End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney International 2001 59 2 407 414 2-s2.0-0035134192 10.1046/j.1523-1755.2001. 059002407.x (Pubitemid 32157905)
20. Meuwese C. L., Snaedal S., Halbesma N., Stenvinkel P., Dekker F. W., Qureshi A. R., Barany P., Heimburger O., Lindholm B., Krediet R. T., Boeschoten E. W., Carrero J. J., Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor- α are similarly associated with survival in haemodialysis patients. Nephrology Dialysis Transplantation 2011 26 4 1313 1318 2-s2.0-79952124894 10.1093/ndt/gfq557
21. Tripepi G., Mallamaci F., Zoccali C., Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. Journal of the American Society of Nephrology 2005 16 3 S83 S88 2-s2.0-20844445415 10.1681/ASN.2004110972 (Pubitemid 41725091)
22. Barreto D. V., Barreto F. C., Liabeuf S., Temmar M., Lemke H. D., Tribouilloy C., Choukroun G., Vanholder R., Massy Z. A., Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney International 2010 77 6 550 556 2-s2.0-77949540909 10.1038/ki.2009.503
23. Ouchi N., Parker J. L., Lugus J. J., Walsh K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011 11 2 85 97 2-s2.0-79151484704 10.1038/nri2921
24. Vaziri N. D., Pahl M. V., Crum A., Norris K., Effect of uremia on structure and function of immune system. Journal of Renal Nutrition 2012 22 1 149 156 10.1053/j.jrn.2011.10.020
25. Steensberg A., Fischer C. P., Keller C., Møller K., Pedersen B. K., IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. American Journal of Physiology-Endocrinology and Metabolism 2003 285 2 E433 E437 2-s2.0-0041846867 (Pubitemid 36899719)
26. Cheung W. W., Paik K. H., Mak R. H., Inflammation and cachexia in chronic kidney disease. Pediatric Nephrology 2010 25 4 711 724 2-s2.0-77951257602 10.1007/s00467-009-1427-z
27. Carrero J. J., Stenvinkel P., Inflammation in end-stage renal disease-what have we learned in 10 years? Seminars in Dialysis 2010 23 5 498 509 2-s2.0-77958516822 10.1111/j.1525-139X.2010.00784.x
28. Kalantar-Zadeh K., Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: what is next? Seminars in Dialysis 2005 18 5 365 369 2-s2.0-27544471849 10.1111/j.1525-139X.2005.00074.x (Pubitemid 41545870)
29. Wilson P. W. F., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B., Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 18 1837 1847 (Pubitemid 28213628)
30. Kalantar-Zadeh K., Ikizler T. A., Block G., Avram M. M., Kopple J. D., Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. American Journal of Kidney Diseases 2003 42 5 864 881 2-s2.0-0142157737 (Pubitemid 37322905)
31. Strassmann G., Fong M., Kenney J. S., Jacob C. O., Evidence for the involvement of interleukin 6 in experimental cancer cachexia. Journal of Clinical Investigation 1992 89 5 1681 1684 2-s2.0-0026689535
32. Pecoits-Filho R., Bárány P., Lindholm B., Heimbürger O., Stenvinkel P., Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrology Dialysis Transplantation 2002 17 9 1684 1688 10.1093/ndt/17.9.1684 (Pubitemid 35012175)
33. Barbieri M., Ferrucci L., Ragno E., Corsi A., Bandinelli S., Bonafé M., Olivieri F., Giovagnetti S., Franceschi C., Guralnik J. M., Paolisso G., Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. American Journal of Physiology-Endocrinology and Metabolism 2003 284 3 E481 E487 2-s2.0-0037372505 (Pubitemid 36237535)
34. Mafra D., Jolivot A., Chauveau P., Drai J., Azar R., Michel C., Fouque D., Are ghrelin and leptin involved in food intake and body mass index in maintenance hemodialysis? Journal of Renal Nutrition 2010 20 3 151 157 2-s2.0-77950923055 10.1053/j.jrn.2009.08.007
35. Cheung W., Yu P. X., Little B. M., Cone R. D., Marks D. L., Mak R. H., Role of leptin and melanocortin signaling in uremia-associated cachexia. Journal of Clinical Investigation 2005 115 6 1659 1665 2-s2.0-20444497662 10.1172/JCI22521 (Pubitemid 40814675)
36. Stenvinkel P., Ketteler M., Johnson R. J., Lindholm B., Pecoits-Filho R., Riella M., Heimbürger O., Cederholm T., Girndt M., IL-10, IL-6, and TNF- α: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney International 2005 67 4 1216 1233 2-s2.0-16244367738 10.1111/j.1523-1755.2005.00200.x (Pubitemid 40463099)
37. Girndt M., Kohler H., Schiedhelm-Weick E., Schlaak J. F., Meyer Zum Buschenfelde K. H., Fleischer B., Production of interleukin-6, tumor necrosis factor α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney International 1995 47 2 559 565 2-s2.0-0028922986
38. Kalantar-Zadeh K., Block G., McAllister C. J., Humphreys M. H., Kopple J. D., Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. The American Journal of Clinical Nutrition 2004 80 2 299 307 2-s2.0-4344560597 (Pubitemid 41080002)
39. American College of Sports Medicine, Exercise is Medicine. 2012, http://exerciseismedicine.org/physicians.htm
40. Kasapis C., Thompson P. D., The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. Journal of the American College of Cardiology 2005 45 10 1563 1569 2-s2.0-18944393401 10.1016/j.jacc.2004.12.077 (Pubitemid 40704486)
41. Bermudez E. A., Rifai N., Buring J., Manson J. E., Ridker P. M., Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 10 1668 1673 2-s2.0-0036791544 10.1161/01.ATV. 0000029781.31325.66
42. Church T. S., Barlow C. E., Earnest C. P., Kampert J. B., Priest E. L., Blair S. N., Associations between cardiorespiratory fitness and C-reactive protein in men. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 11 1869 1876 2-s2.0-0036847365 10.1161/01.ATV.0000036611.77940.F8 (Pubitemid 35315775)
43. Colbert L. H., Visser M., Simonsick E. M., Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study. Journal of the American Geriatrics Society 2004 52 7 1098 1104 10.1111/j.1532-5415.2004.52307.x (Pubitemid 38869068)
44. Elosua R., Bartali B., Ordovas J. M., Corsi A. M., Lauretani F., Ferrucci L., Association between physical activity, physical performance, and inflammatory biomarkers in an elderly population: the InCHIANTI study. Journals of Gerontology. A. Biological Sciences and Medical Sciences 2005 60 6 760 767 2-s2.0-21144432015 (Pubitemid 40881184)
45. Shanely R. A., Nieman D. C., Henson D. A., Jin F., Knab A. M., Sha W., Inflammation and oxidative stress are lower in physically fit and active adults. Scandinavian Journal of Medicine and Science in Sports 2011 23 2 215 223 10.1111/j.1600-0838.2011.01373.x
46. Hamer M., Sabia S., Batty G. D., Shipley M. J., Tabák A. G., Singh-Manoux A., Kivimaki M., Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study. Circulation 2012 126 8 928 933 10.1161/CIRCULATIONAHA.112.103879
47. Christiansen T., Paulsen S. K., Bruun J. M., Pedersen S. B., Richelsen B., Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. American Journal of Physiology-Endocrinology and Metabolism 2010 298 4 E824 E831 2-s2.0-77949868472 10.1152/ajpendo.00574.2009
48. Church T. S., Earnest C. P., Thompson A. M., Priest E. L., Rodarte R. Q., Saunders T., Ross R., Blair S. N., Exercise without weight loss does not reduce C-reactive protein: the INFLAME study. Medicine and Science in Sports and Exercise 2010 42 4 708 716 2-s2.0-78650446711 10.1249/MSS.0b013e3181c03a43
49. Stewart L. K., Earnest C. P., Blair S. N., Church T. S., Effects of different doses of physical activity on C-reactive protein among women. Medicine and Science in Sports and Exercise 2010 42 4 701 707 2-s2.0-78650435591 10.1249/MSS.0b013e3181c03a2b
50. Thompson D., Markovitch D., Betts J. A., Mazzatti D., Turner J., Tyrrell R. M., Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial. Journal of Applied Physiology 2010 108 4 769 779 2-s2.0-77950575040 10.1152/japplphysiol.00822.2009
51. Gleeson M., Bishop N. C., Stensel D. J., Lindley M. R., Mastana S. S., Nimmo M. A., The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nature Reviews Immunology 2011 11 9 607 615 10.1038/nri3041
52. Uguccioni M., D'Apuzzo M., Loetscher M., Dewald B., Baggiolini M., Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 α and MIP-1 β on human monocytes. European Journal of Immunology 1995 25 1 64 68 2-s2.0-0028897310
53. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T. F. E., Dragun D., Skurk T., Hauner H., Blüher M., Unger T., Wolf A. M., Knippschild U., Hombach V., Marx N., T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1304 1310 2-s2.0-46249117032 10.1161/ATVBAHA.108.165100
54. Keophiphath M., Rouault C., Divoux A., Clément K., Lacasa D., CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 1 39 45 2-s2.0-73849125378 10.1161/ATVBAHA.109.197442
55. Abramson J. L., Vaccarino V., Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Archives of Internal Medicine 2002 162 11 1286 1292 2-s2.0-0037054033 (Pubitemid 34595035)
56. Pedersen B. K., Febbraio M. A., Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiological Reviews 2008 88 4 1379 1406 2-s2.0-55949119252 10.1152/physrev.90100.2007
57. Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B. K., Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. Journal of Physiology 1999 515 part 1 287 291 2-s2.0-0033557703 (Pubitemid 29092641)
58. Fischer C. P., Interleukin-6 in acute exercise and training: what is the biological relevance? Exercise Immunology Review 2006 12 6 33 2-s2.0-33947529793
59. Peake J. M., Nosaka K., Muthalib M., Suzuki K., Systemic inflammatory responses to maximal versus submaximal lengthening contractions of the elbow flexors. Exercise Immunology Review 2006 12 72 85 2-s2.0-33947514541
60. Phillips M. D., Mitchell J. B., Currie-Elolf L. M., Yellott R. C., Hubing K. A., Influence of commonly employed resistance exercise protocols on circulating IL-6 and indices of insulin sensitivity. Journal of Strength and Conditioning Research 2010 24 4 1091 1101 2-s2.0-77950637729 10.1519/JSC.0b013e3181cc2212
61. Keller C., Steensberg A., Hansen A. K., Fischer C. P., Plomgaard P., Pedersen B. K., Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. Journal of Applied Physiology 2005 99 6 2075 2079 2-s2.0-28044442051 10.1152/japplphysiol.00590.2005 (Pubitemid 41691622)
62. Pedersen B. K., Fischer C. P., Beneficial health effects of exercise-the role of IL-6 as a myokine. Trends in Pharmacological Sciences 2007 28 4 152 156 10.1016/j.tips.2007.02.002 (Pubitemid 46505167)
63. Flynn M. G., McFarlin B. K., Toll-like receptor 4: link to the anti-inflammatory effects of exercise? Exercise and Sport Sciences Reviews 2006 34 4 176 181 2-s2.0-33749842958 10.1249/01.jes.0000240027.22749.14 (Pubitemid 44562942)
64. Gleeson M., McFarlin B., Flynn M., Exercise and Toll-like receptors. Exercise Immunology Review 2006 12 34 53 2-s2.0-33947544182
65. Stengel B., Tarver-Carr M. E., Powe N. R., Eberhardt M. S., Brancati F. L., Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003 14 4 479 487 2-s2.0-0142058881 10.1097/01.EDE.0000071413. 55296.c4 (Pubitemid 40417067)
66. Bharakhada N., Yates T., Davies M. J., Association of sitting time and physical activity with CKD: a cross-sectional study in family practices. American Journal of Kidney Diseases 2012 60 4 583 590 10.1053/j.ajkd.2012.04.024
67. O'Hare A. M., Tawney K., Bacchetti P., Johansen K. L., Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2. American Journal of Kidney Diseases 2003 41 2 447 454 2-s2.0-0037311002 10.1053/ajkd.2003.50055 (Pubitemid 36152466)
68. Stack A. G., Molony D. A., Rives T., Tyson J., Murthy B. V. R., Association of physical activity with mortality in the US dialysis population. American Journal of Kidney Diseases 2005 45 4 690 701 2-s2.0-16244383182 10.1053/j.ajkd.2004.12.013 (Pubitemid 40460757)
69. Akber A., Portale A. A., Johansen K. L., Pedometer-assessed physical activity in children and young adults with CKD. Clinical Journal of the American Society of Nephrology 2012 7 5 720 726 10.2215/CJN.06330611
70. Johansen K. L., Painter P., Exercise in individuals with CKD. American Journal of Kidney Diseases 2011 59 1 126 134
71. Brodin E., Ljungman S., Sunnerhagen K. S., Rising from a chair: a simple screening test for physical function in predialysis patients. Scandinavian Journal of Urology and Nephrology 2008 42 3 293 300 2-s2.0-42449111733 10.1080/00365590701797556 (Pubitemid 351574394)
72. Padilla J., Krasnoff J., Da Silva M., Hsu C. Y., Frassetto L., Johansen K. L., Painter P., Physical functioning in patients with chronic kidney disease. Journal of Nephrology 2008 21 4 550 559 2-s2.0-52649140580
73. Fassett R. G., Robertson I. K., Geraghty D. P., Ball M. J., Burton N. W., Coombes J. S., Physical activity levels in patients with chronic kidney disease entering the LORD trial. Medicine and Science in Sports and Exercise 2009 41 5 985 991 2-s2.0-67650095678 10.1249/MSS.0b013e3181940aef
74. Clyne N., Jogestrand T., Lins L. E., Pehrsson S. K., Progressive decline in renal function induces a gradual decrease in total hemoglobin and exercise capacity. Nephron 1994 67 3 322 326 2-s2.0-0028229862 (Pubitemid 24177641)
75. Segura-Orti E., Gordon P. L., Doyle J. W., Physical functioning in chronic kidney disease: contribution of uremia. Journal of the American Society of Nephrology 2010 21 669A 670A
76. Baria F., Kamimura M. A., Avesani C. M., Lindholm B., Stenvinkel P., Draibe S. A., Cuppari L., Activity-related energy expenditure of patients undergoing hemodialysis. Journal of Renal Nutrition 2011 21 3 226 234 2-s2.0-79955104990 10.1053/j.jrn.2010.06.022
77. Gordon P. L., Doyle J. W., Johansen K. L., Postdialysis fatigue is associated with sedentary behavior. Clinical Nephrology 2011 75 5 426 433 2-s2.0-79958700736
78. Anand S., Chertow G. M., Johansen K. L., Grimes B., Kurella Tamura M., Dalrymple L. S., Kaysen G. A., Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the Comprehensive Dialysis Study. Journal of Renal Nutrition 2011 21 6 429 437 10.1053/j.jrn.2010.09.007
79. Mafra D., Deleaval P., Teta D., Cleaud C., Arkouche W., Jolivot A., Fouque D., Influence of inflammation on total energy expenditure in hemodialysis patients. Journal of Renal Nutrition 2011 21 5 387 393 10.1053/j.jrn.2010.09. 006
80. Zamojska S., Szklarek M., Niewodniczy M., Nowicki M., Correlates of habitual physical activity in chronic haemodialysis patients. Nephrology Dialysis Transplantation 2006 21 5 1323 1327 2-s2.0-33646200349 10.1093/ndt/gfi323
81. Shiraishi F. G., Stringuetta Belik F., e Silva O., Inflammation, diabetes, and chronic kidney disease: role of aerobic capacity. Experimental Diabetes Research 2012 2012 6 10.1155/2012/750286 750286
82. Kosmadakis G. C., Bevington A., Smith A. C., Clapp E. L., Viana J. L., Bishop N. C., Feehally J., Physical exercise in patients with severe kidney disease. Nephron-Clinical Practice 2010 115 1 c7 c15 2-s2.0-76749104274 10.1159/000286344
83. Heiwe S., Jacobson S. H., Exercise training for adults with chronic kidney disease. Cochrane Database of Systematic Reviews 2011 10 CD003236 10.1002/14651858.CD003236.pub2
84. Daniilidis M., Kouidi E., Fleva A., The immune response in hemodialysis patients following physical training. Journal of Sport Sciences for Health 2004 1 1 11 16 10.1007/s11332-004-0003-y
85. Cheema B. S. B., Abas H., Smith B. C., Effect of resistance training during hemodialysis on circulating cytokines: a randomized controlled trial. European Journal of Applied Physiology 2011 111 7 1437 1445 10.1007/s00421-010- 1763-5
86. Kopple J. D., Wang H., Casaburi R., Fournier M., Lewis M. I., Taylor W., Storer T. W., Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. Journal of the American Society of Nephrology 2007 18 11 2975 2986 2-s2.0-35948999322 10.1681/ASN.2006070794 (Pubitemid 350064083)
87. Toussaint N. D., Polkinghorne K. R., Kerr P. G., Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients. Hemodialysis International 2008 12 2 254 263 2-s2.0-41849100775 10.1111/j.1542-4758.2008.00262.x (Pubitemid 351494281)
88. Wilund K. R., Tomayko E. J., Wu P. T., Ryong Chung H., Vallurupalli S., Lakshminarayanan B., Fernhall B., Intradialytic exercise training reduces oxidative stress and epicardial fat: a pilot study. Nephrology Dialysis Transplantation 2010 25 8 2695 2701 2-s2.0-77954795100 10.1093/ndt/gfq106
89. Gołȩbiowski T., Kusztal M., Weyde W., A program of physical rehabilitation during hemodialysis sessions improves the fitness of dialysis patients. Kidney and Blood Pressure Research 2012 35 4 290 296 10.1159/000335411
90. Załuska A., Załuska W. T., Bednarek-Skublewska A., Ksiazek A., Nutrition and hydration status improve with exercise training using stationary cycling during hemodialysis (HD) in patients with end-stage renal disease (ESRD). Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 2002 57 2 342 346 2-s2.0-0642337519
91. Nindl B. C., Headley S. A., Tuckow A. P., Pandorf C. E., Diamandi A., Khosravi M. J., Welles R., Jones M., Germain M., IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients. Growth Hormone & IGF Research 2004 14 3 245 250 2-s2.0-2542450969 10.1016/j.ghir.2004.01.007 (Pubitemid 38684506)
92. Cheema B., Abas H., Smith B., O'Sullivan A., Chan M., Patwardhan A., Kelly J., Gillin A., Pang G., Lloyd B., Singh M. F., Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. Journal of the American Society of Nephrology 2007 18 5 1594 1601 2-s2.0-34248389365 10.1681/ASN.2006121329 (Pubitemid 46729199)
93. Afshar R., Shegarfy L., Shavandi N., Sanavi S., Effects of aerobic exercise and resistance training on lipid profiles and inflammation status in patients on maintenance hemodialysis. Indian Journal of Nephrology 2010 20 4 185 189 2-s2.0-78650110397 10.4103/0971-4065.73442
94. Afshar R., Emany A., Saremi A., Shavandi N., Sanavi S., Effects of intradialytic aerobic training on sleep quality in hemodialysis patients. Iranian Journal of Kidney Diseases 2011 5 2 119 123 2-s2.0-79958747551
95. Headley S., Germain M., Mailloux P., Mulhern J., Ashworth B., Burris J., Brewer B., Nindl B., Coughlin M., Welles R., Jones M., Resistance training improves strength and functional measures in patients with end-stage renal disease. American Journal of Kidney Diseases 2002 40 2 355 364 2-s2.0-0036326142 10.1053/ajkd.2002.34520 (Pubitemid 34827654)
96. Castaneda C., Gordon P. L., Parker R. C., Uhlin K. L., Roubenoff R., Levey A. S., Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. American Journal of Kidney Diseases 2004 43 4 607 616 2-s2.0-1642422907 10.1053/j.ajkd.2003.12.025 (Pubitemid 38401875)
97. Headley S., Germain M., Milch C., Exercise Training Improves HR responses and VO2peak in Predialysis Kidney Patients. Medicine and Science in Sports and Exercise 2012 44 12 2392 2399 10.1249/MSS.0b013e318268c70c
98. Leehey D. J., Moinuddin I., Bast J. P., Qureshi S., Jelinek C. S., Cooper C., Edwards L. C., Smith B. M., Collins E. G., Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study. Cardiovascular Diabetology 2009 8, article 62 2-s2.0-73449107150 10.1186/1475-2840-8-62
99. Haddad F., Zaldivar F., Cooper D. M., Adams G. R., IL-6-induced skeletal muscle atrophy. Journal of Applied Physiology 2005 98 3 911 917 2-s2.0-14144252542 10.1152/japplphysiol.01026.2004 (Pubitemid 40283672)
100. Macy E. M., Hayes T. E., Tracy R. P., Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clinical Chemistry 1997 43 1 52 58 2-s2.0-0031021084 (Pubitemid 27024390)
101. Eustace J. A., Astor B., Muntner P. M., Ikizler T. A., Coresh J., Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney International 2004 65 3 1031 1040 2-s2.0-1342322647 10.1111/j.1523-1755.2004.00481.x (Pubitemid 38251079)
102. Borg G. A. V., Perceived exertion: a note on " history" and methods. Medicine and Science in Sports and Exercise 1973 5 2 90 93
103. Kadoglou N. P. E., Iliadis F., Angelopoulou N., Perrea D., Ampatzidis G., Liapis C. D., Alevizos M., The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. European Journal of Cardiovascular Prevention and Rehabilitation 2007 14 6 837 843 2-s2.0-36649035989 10.1097/HJR.0b013e3282efaf50 (Pubitemid 350197015)
104. Trøseid M., Lappegrd K. T., Mollnes T. E., Arnesen H., Seljeflot I., The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome. Metabolic Syndrome and Related Disorders 2009 7 6 579 583 2-s2.0-73649129621 10.1089/met.2009.0003
105. Goldhammer E., Tanchilevitch A., Maor I., Beniamini Y., Rosenschein U., Sagiv M., Exercise training modulates cytokines activity in coronary heart disease patients. International Journal of Cardiology 2005 100 1 93 99 2-s2.0-16844376949 10.1016/j.ijcard.2004.08.073 (Pubitemid 40487942)
106. Larsen A. I., Aukrust P., Aarsland T., Dickstein K., Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure. American Journal of Cardiology 2001 88 7 805 808 2-s2.0-0035487711
107. Petersen A. M. W., Pedersen B. K., The anti-inflammatory effect of exercise. Journal of Applied Physiology 2005 98 4 1154 1162 2-s2.0-15444374348 10.1152/japplphysiol.00164.2004 (Pubitemid 40396484)
108. Garibotto G., Sofia A., Procopio V., Villaggio B., Tarroni A., Di Martino M., Cappelli V., Gandolfo M. T., Aloisi F., De Cian F., Sala M. R., Verzola D., Peripheral tissue release of interleukin-6 in patients with chronic kidney diseases: effects of end-stage renal disease and microinflammatory state. Kidney International 2006 70 2 384 390 2-s2.0-33746106471 10.1038/sj.ki.5001570 (Pubitemid 44086590)
109. Romano G., Simonella R., Falleti E., Bortolotti N., Deiuri E., Antonutto G., De Vita S., Ferraccioli G. F., Montanaro D., Physical training effects in renal transplant recipients. Clinical Transplantation 2010 24 4 510 514 2-s2.0-77955725348 10.1111/j.1399-0012.2009.01098.x
110. MacLaughlin H. L., Sarafidis P. A., Greenwood S. A., Campbell K. L., Hall W. L., Macdougall I. C., Compliance with a structured weight loss program is associated with reduced systolic blood pressure in obese patients with chronic kidney disease. American Journal of Hypertension 2012 25 9 1024 1029 10.1038/ajh.2012.80
111. Axelsson J., Qureshi A. R., Suliman M. E., Honda H., Pecoits-Filho R., Heimbürger O., Lindholm B., Cederholm T., Stenvinkel P., Truncal fat mass as a contributor to inflammation in end-stage renal disease. The American Journal of Clinical Nutrition 2004 80 5 1222 1229 2-s2.0-11844300847 (Pubitemid 41350682)
112. Merino A., Buendia P., Martin-Malo A., Aljama P., Ramirez R., Carracedo J., Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. Journal of Immunology 2011 186 3 1809 1815 2-s2.0-79251538661 10.4049/jimmunol.1001866
113. Belge K. U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., Espevik T., Ziegler-Heitbrock L., The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. Journal of Immunology 2002 168 7 3536 3542 2-s2.0-0036533648 (Pubitemid 34250422)
114. Gollapudi P., Yoon J. W., Gollapudi S., Pahl M. V., Vaziri N. D., Leukocyte toll-like receptor expression in end-stage kidney disease. American Journal of Nephrology 2010 31 3 247 254 2-s2.0-74249111667 10.1159/000276764
115. Hendrikx T. K., van Gurp E. A. F. J., Mol W. M., Schoordijk W., Sewgobind V. D. K. D., Ijzermans J. N. M., Weimar W., Baan C. C., End-stage renal failure and regulatory activities of CD4 +CD25bright+FoxP3+ T-cells. Nephrology Dialysis Transplantation 2009 24 6 1969 1978 2-s2.0-67249139595 10.1093/ndt/gfp005
116. Meier P., Golshayan D., Blanc E., Pascual M., Burnier M., Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. Journal of the American Society of Nephrology 2009 20 6 1368 1384 10.1681/ASN.2008070734